For example, a study by Han Q et al. in 2024 [17] used GelMA microspheres loaded with a heparin–dopamine conjugate and Hepatocyte Growth Factor (HGF) to mitigate oxidative stress and inflammation in tendinopathy. This evidence concerns the gene HGF and disease of the tendon.